Chinese Health and Pharmaceutical Enterprises Can 
Leverage AI Technology and the Capital Market for 
High-Quality Development

Peng Shen

doi:10.70711/mhr.v2i4.5484

Chinese Health and Pharmaceutical Enterprises Can Leverage AI Technology and the Capital Market for High-Quality Development

Peng Shen

Abstract

Combining extensive research in the medical and health industry with entrepreneurial practices in the field by Waterdrop Inc., which
operates Waterdrop Medical Crowdfunding, Waterdrop Insurance Marketplace, and Yifan CRO, this paper delves into how Chinese medical
and health enterprises can harness the power of capital markets and AI technology to foster corporate growth and industry innovation. It examines the policy background, AI technology trends, and capital market development trends in Chinas medical and health industry to provide
insights into strategic approaches for leveraging these resources.

Keywords

Capital Market; Medical and Health Industry; High-Quality Development; AI+Medical; Large Models

Full Text:

PDF

Included Database

References

[1] Chinese Communist Party. "Report at the 20th National Congress of the Communist Party of China." 2022.

[2] State Council. "Healthy China 2030 Plan Outline." 2016.

[3] State Council. "14th Five-Year National Health Plan." 2021.

[4] CEC Capital. "CEC Capital China Health Industry White Paper." 2019-2024.

[5] National Population Development Plan. "National Population Development Plan (2016-2030)." 2016.

DOI: http://dx.doi.org/10.70711/mhr.v2i4.5484

Refbacks

There are currently no refbacks.